Net Cash Provided by (Used in) Financing Activities |
1.6K |
USD |
|
Q2 2022 |
Q1 2022 |
Net Cash Provided by (Used in) Investing Activities |
0 |
USD |
|
Q2 2022 |
Q1 2022 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q4 2022 |
Q3 2022 |
Common Stock, Shares, Issued |
100M |
shares |
0% |
Q4 2022 |
Q3 2022 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2022 |
Q3 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-343 |
USD |
+91.3% |
Q2 2022 |
Q1 2022 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
422 |
USD |
-96.1% |
Q1 2022 |
FY 2022 |
Deferred Tax Assets, Operating Loss Carryforwards |
250K |
USD |
+6.33% |
Q1 2022 |
FY 2022 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q4 2022 |
Q3 2022 |
Additional Paid in Capital |
6.88M |
USD |
0% |
Q4 2022 |
Q3 2022 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2022 |
Q3 2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2022 |
Q3 2022 |